Please login to the form below

Not currently logged in
Email:
Password:

PfSPZ

This page shows the latest PfSPZ news and features for those working in and with pharma, biotech and healthcare.

Dosing of GSK's malaria vaccine due to start in 2018

Dosing of GSK's malaria vaccine due to start in 2018

Another malaria vaccine developed by US biopharma company Sanaria – called PfSPZ – has been shown to offer improved protection rates, possibly as high as 80%, as well as a duration of action

Latest news

  • Malaria vaccine is first to provide 'sustained protection' Malaria vaccine is first to provide 'sustained protection'

    The PfSPZ vaccine had previously been shown to provide a short-term immunological response targeted at the malaria parasite, but in the latest trial was shown to provide protection against infection ... Sanaria chief executive Stephen Hoffmann said that

  • Scientists finds new drug target for malaria Scientists finds new drug target for malaria

    In August NIV researchers said they had achieved "unprecedented" results in a small study of a weakened, live Plasmodium falciparum vaccine called PfSPZ.

  • GSK hoping to file malaria vaccine next year GSK hoping to file malaria vaccine next year

    In the summer, researcher at the US National Institutes of Health (NIH) reported encouraging early clinical of another candidate called PfSPZ - in development at small US biotech Sanaria - which provided complete

  • Malaria vaccine gives Malaria vaccine gives "unprecedented" results

    At the highest dose tested, vaccination with the PfSPZ shot provided complete protection against malaria in six patients. ... The researchers found that participants who received a higher total dosage of PfSPZ generated more antibodies against malaria

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics